[ Apr 30, 2021 ]
Methocarbamol Tablets got FDA Approval on 4/30/2021
METHOCARBAMOL TABLETS, USP, 500 MG- methocarbamol tablet, film
coated
METHOCARBAMOL TABLETS, USP, 750 MG- methocarbamol tablet, film
coated
Methocarbamol Tablets, USP, a carbamate derivative of guaifenesin, is a central nervous
system (CNS) depressant with sedative and musculoskeletal relaxant properties.
The chemical name of methocarbamol is 3-(2-methoxyphenoxy)-1,2-propanediol 1-
carbamate and has the empirical formula C11H15NO5. Its molecular weight is 241.24.
The structural formula is shown below.
Methocarbamol is a white powder, sparingly soluble in water and chloroform, soluble in
alcohol (only with heating) and propylene glycol, and insoluble in benzene and n-hexane.
Methocarbamol Tablets, USP 500 mg are available as a white, round, scored, film-coated
tablet containing 500 mg of methocarbamol, USP for oral administration. The inactive
ingredients present are microcrystalline cellulose, croscarmellose sodium, povidone (k-
30), sodium lauryl sulfate, colloidal silicon dioxide, magnesium stearate, hypromellose,
titanium dioxide, polyethylene glycol, polysorbate 80.